Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO and HAIFA, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) announced today that it has been accepted to...
-
TORONTO and HAIFA, Israel and INDIANAPOLIS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical...
-
NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update
-
NurExone’s Groundbreaking Exosome Therapies to be Showcased at Fall U.S. Conferences
-
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
-
ROCHESTER, N.Y., March 8, 2016 (GLOBE NEWSWIRE) -- Whether you invest in stocks, bonds, commodities, or currencies, the carry trade is one of the most popular trading strategies in the currency...